Spectrum Vascular Secures Strategic Investment from SK Capital

SK Capital Partners, a New York-based private equity firm specializing in specialty materials, ingredients, and life sciences sectors, has announced a strategic investment in Spectrum Vascular, a company providing innovative vascular access and medication management products. This move marks a recapitalization effort alongside existing majority investor Event Capital Strategies (ECS), an investment firm based in New York and focused on medical technology. Spectrum Vascular was formed following acquisitions of the vascular access businesses of Cook Medical and AngioDynamics. SK Capital's involvement is expected to optimize Spectrum's growth trajectory, leveraging their significant resources and investment expertise to enhance the company's mission of improving patient care and market delivery of advanced medical technologies. Legal counsel for the transaction was provided by Kirkland & Ellis LLP for SK Capital and Fried Frank LLP for ECS, with debt financing organized by KeyBank, Beachpoint Direct Lending Fund, Apogem Capital, and Kayne Anderson Private Credit.